Irish journal of medical science
Is Mirabegron-the novel beta 3 agonist-effective in patients with heart failure? A systematic review and meta-analysis of efficacy and safety.
Amr Elrosasy, Mohamed Abo Zeid, Mohamed A Aldemerdash, Khalid Sarhan, Raghad Samha, Yaser AbuSammour, Refaat A Eid, Salim Jamil, Sameh Nassar
Published: 202610.1007/s11845-025-04165-2
Abstract
OBJECTIVE: Our goal is to conduct an investigation into the safety and efficacy of 𝛽3 agonist (Mirabegron) in patients with heart failure (HF) comparing it to placebo. METHODS: We searched internet databases for eligible randomized controlled trials…
Preview only. Read the full abstract at the source